Edges in Network
| Network | GSE5851_egf1520 - GSE5851 - SiGN-BN HC+Bootstrap |
| Network Description | Phase II exploratory pharmacogenomics study of cetuximab monotherapy in patients with advanced metastatic CRC |
| Node | SYK |
| Upstream (Parents) |
|---|
| (<<) CFL1 → SYK |
| (<<) CSNK1D → SYK |
| (<<) EFHD2 → SYK |
| (<<) ELF3 → SYK |
| (<<) ELF4 → SYK |
| (<<) FUT4 → SYK |
| (<<) GOT1 → SYK |
| (<<) MAT2A → SYK |
| (<<) NDRG1 → SYK |
| (<<) NUDT6 → SYK |
| (<<) RDX → SYK |
| (<<) RNASE4 → SYK |
| (<<) TMSB10 → SYK |
| Downstream (Children) |
|---|
| SYK → ATP2A2 (>>) |
| SYK → CD83 (>>) |
| SYK → CHST11 (>>) |
| SYK → GNB2 (>>) |
| SYK → NRG1 (>>) |
| SYK → PCSK7 (>>) |
| SYK → PHGDH (>>) |
| SYK → PRDX6 (>>) |
| SYK → PTK7 (>>) |
| SYK → THRA (>>) |
| SYK → TNFRSF11A (>>) |
| SYK → TSC22D1 (>>) |
| SYK → VCP (>>) |
